ARECOR THERAPEUTICS PLC (AREC) — Results

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arecor Therapeutics Plc.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04b9a-d2ff-7942-be54-299dfc9b5454 Created: 2026-08-29T03:42:57.388Z Duration: 3594.315 Channels: 1 00:00:01.280 -- 00:00:04.240 Good afternoon, and welcome to the ARECOR THERAPEUTICS 00:00:04.240 -- 00:00:06.160 PLC Investor Presentation. 00:00:06.399 -- 00:00:08.960 Throughout this recorded presentation, investors will be in 00:00:08.960 -- 00:00:11.679 listen only mode. Questions are encouraged and can 00:00:11.679 -- 00:00:13.280 be submitted at any time via the Q 00:00:13.280 -- 00:00:15.120 and A tab situated on the right hand 00:00:15.120 -- 00:00:17.175 corner of your screen. Simply type in your 00:00:17.175 -- 00:00:19.655 questions and press send. The company may not 00:00:19.655 -- 00:00:21.255 be in a position to answer every question 00:00:21.255 -- 00:00:23.495 it receives during the meeting itself. However, the 00:00:23.495 -- 00:00:25.654 company will review all questions submitted today and 00:00:25.654 -- 00:00:27.575 publish responses where it is appropriate to do 00:00:27.575 -- 00:00:29.620 so. Before we begin, I'd like to submit 00:00:29.620 -- 00:00:31.700 the following poll. I'd now like to hand 00:00:31.700 -- 00:00:34.180 you over to Sarah Howe, CEO. Good afternoon. 00:00:34.980 -- 00:00:37.780 Great. Thank you, Lily. Good afternoon, everybody. Thank 00:00:37.780 -- 00:00:40.739 you for joining us today. So 00:00:41.060 -- 00:00:42.580 we'll be talking through 00:00:42.925 -- 00:00:43.965 ARECOR's 00:00:43.965 -- 00:00:49.485 full results for the year ending 12/31/2022. 00:00:50.445 -- 00:00:52.445 So I draw your attention to our customary 00:00:52.445 -- 00:00:53.644 legal notice. 00:00:54.524 -- 00:00:57.500 So today, it's myself. I've got Sarah Howell. 00:00:57.500 -- 00:01:00.0...